Case Report: Tuberculosis Verrucosa Cutis That Mimics Atypical Mycobacterium Cutaneous Infection
Keywords:
cutaneous tuberculosis, tuberculosis verrucosa cutis, mycobacteriaAbstract
Tuberculosis verrucosa cutis (TBVC) is a rare diagnosis, which often underdiagnosed and was delayed for treatment. Case: We present a case of TBVC of a twenty-eight-year-old man with complain of a painless verrucous nodule coaslesced from tiny nodules, that sometimes bleed. The patient had history of pulmonary TB contact from his friend, but symptoms, laboratory tests (complete blood count, erythrocyte sedimentation rate, transaminase, urea, and creatinine), and lung radiograph were unremarkable. The patient had no history of chronic ilness, vaccination history was completed. histopathology result showed small foci containing epithelioid cells that surrounded granuloma with suggestive caseous necrosis with no sign of malignancy and positive acid fast bacilli in paraffin section. The patient was treated with first line antituberculous drugs regimen, that includes isoniazid, rifampicin, ethambutol, and pirazinamid. After 6 months, the lesion improved significantly and the patient did not feel any pain or bleed in the lesion. There was no recurrence on follow up 5 months post therapy. Discussion: The major risk factors for development of cutaneous TB are increased exposure to the source of infection. Diagnosis of TBVC lies in identifying the presence of etiology either by histopathology, PCR, or other methods with various sensitivity and specificity. Conclusion: Cutaneous infection of TB might present in various manifestation with multiple differentials and multiple diagnostic modalities that vary in diagnostic accuracy. The trial of TB therapy may be justified and diagnosed based on the improvement after therapy.References
Horsburgh CRJ, Barry CEI, Lange C. Treatment of tuberculosis. N Eng J Med. 2015;373(22):2149–60.
World Health Organization [WHO]. Global tuberculosis report 2021. WHO. 2021. Available from: https://www.who.int/publications/i/item/9789240037021
Letang E, Ellis J, Naidoo K, Casas EC, Sánchez P, Hassan-Moosa R, et al. Tuberculosis-HIV co-infection: progress and challenges after two decades of global antiretroviral treatment roll-out. Arch Bronconeumol. 2020;56(7):446–54.
World Health Organization [WHO]. Tuberculosis.WHO. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis
Van Zyl L, Du Plessis J, Viljoen J. Cutaneous tuberculosis overview and current treatment regimens. Tuberculosis. 2015;95(6):629–38.
Chen Q, Chen WC, Hao F. Cutaneous tuberculosis: A great imitator. Clin Dermatol. 2019;37(3):192–9.
Kumar B, Dogra S. Cutaneous tuberculosis. Ski Infect Diagnosis Treat. 2021;59–75.
Barbagallo J, Tager P, Ingleton R, Hirsch RJ, Weinberg JM. Cutaneous tuberculosis: Diagnosis and treatment. Am J Clin Dermatol. 2002;3(5):319–28.
Roelan T. Practical Review of diagnosis and management of cutaneous tuberculosis in Indonesia. Eur J Med Heal Sci. 2021;3(5):25–30.
Dwari B, Ghosh A, Paudel R, Kishore P. A clinicoepidemiological study of 50 cases of cutaneous tuberculosis in a tertiary care teaching hospital in pokhara, Nepal. Indian J Dermatol. 2010;55(3):233–7.
Puri N. A clinical and histopathological profile of patients with cutaneous tuberculosis. Indian J Dermatol. 2011;56(5):550–2.
Handog EB, Gabriel TG, Pineda RT V. Management of cutaneous tuberculosis. Dermatol Ther. 2008;21(3):154–61.
Macgregor RR. Cutaneous tuberculosis. Clin Dermatol. 1995;13(3):245–55.
M Prathyusha, Sainudheen A, Puthean S. Tuberculosis verucossa cutis of hand: A case report. Nepal J Dermatology, Venereol Leprol. 2021;19(2):65–9.
Roelan T. Practical review of Diagnosis and management of cutaneous tuberculosis in Indonesia. Eur J Med Heal Sci. 2021;3(5):25-30.
Pebriany D, Anwar AI, Djamaludin W, Adriani A, Amin S. Successful diagnosis and management of tuberculosis verrucosa cutis using antituberculosis therapy trial approach. Pan Afr Med J. 2020;37:1–8.
dos Santos JB, Figueiredo AR, Ferraz CE, de Oliveira MH, da Silva PG, de Medeiros VLS. Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinicalaspects - Part I. An Bras Dermatol. 2014;89(2):219.
Ghosh S, Aggarwal K, Jain VK, Chaudhuri S, Ghosh E, Arshdeep A. Tuberculosis verrucosa cutis presenting as diffuse plantar keratoderma: An unusual sight. Indian J Dermatol. 2014;59(1):80.
Murry WT, Sharma S, Arora VK, Bhattacharya SN, Singal A. Cytomorphological spectrum and immunochemistry of cutaneous tuberculosis. Diagn Cytopathol. 2019;47(5):458–68.
Chatterjee D, Saikia UN, Ramesh V. Diagnostic dilemma of cutaneous tuberculosis: opening of the pandora’s box. Am J Dermatopathol. 2021;43(12):871–80.
Kim G, Jeong YI, Huh JW, Kim EJ, Joh OJ. Interferon-gamma release assay in a patient with tuberculosis verrucosa cutis. Ann Dermatol. 2015;27(1):109–10.
Mann D, Sant’Anna FM, Schmaltz CAS, Rolla V, Freitas DFS, Lyra MR, et al. Cutaneous tuberculosis in Rio de Janeiro, Brazil: description of a series of 75 cases. Int J Dermatol. 2019;58(12):1451–9.
Indonesia Ministry of Health (MoH). National guidelines for management of tuberculosis. Jakarta: Ministry of Health. 2019.
Badrinath M, John S. Isoniazid toxicity. J Am Med Assoc. 2018;168(12):1685.
Dias MFRG, Bernardes Filho F, Quaresma MV, do Nascimento LV, Nery JA da C, Azulay DR. Update on cutaneous tuberculosis. An Bras Dermatol. 2014;89(6):925.
Assiri A, Euvrard S, Kanitakis J. Cutaneous Mycobacterium marinum infection (fish tank granuloma) in a renal transplant recipient: case report and literature review. Cureus. 2019;11(10).
Chung J, Ince D, Ford BA, Wanat KA. Cutaneous infections due to nontuberculosis mycobacterium: recognition and management. Am J Clin Dermatology. 2018;19(6):867–78.
Johnson MG, Stout JE. Twenty-eight cases of Mycobacterium marinum infection: retrospectivecase series and literature review. Infection. 2015;43:655-62.
Terziroli Beretta-Piccoli B, Mainetti C, Peeters MA, Laffitte E. Cutaneous granulomatosis: A comprehensive review. Clin Rev Allergy Immunol. 2018;54(1):131–46.
Gardini G, Gregori N, Matteelli A, Castelli F. Mycobacterial skin infection. Curr Opin Infect Dis. 2022;35(2):79–87.